Global POCT Molecular Diagnostics Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “POCT Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world POCT Molecular Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected POCT Molecular Diagnostics sales for 2023 through 2029. With POCT Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global POCT Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global POCT Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Molecular Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Molecular Diagnostics.
The global POCT Molecular Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key POCT Molecular Diagnostics players cover Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene and Sansure Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Molecular Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global POCT Molecular Diagnostics market?
What factors are driving POCT Molecular Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POCT Molecular Diagnostics market opportunities vary by end market size?
How does POCT Molecular Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “POCT Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world POCT Molecular Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected POCT Molecular Diagnostics sales for 2023 through 2029. With POCT Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global POCT Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global POCT Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Molecular Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Molecular Diagnostics.
The global POCT Molecular Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for POCT Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key POCT Molecular Diagnostics players cover Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene and Sansure Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of POCT Molecular Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Molecular Point-of-Care Diagnostics
- Near-Patient Molecular
- Microbiology Laboratory
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ustar Biotechnologies (Hangzhou) Ltd.
- Cepheid
- Abbott Laboratories
- Roche Holding AG
- BioFire Diagnostics
- Beijing Bohui Innovat Biotech Grp Co Ltd.
- CapitalBio Corporation
- Daan Gene
- Sansure Biotech
- Coyote Bioscience Co., Ltd.
- Genmark Diagnostics, Inc.
- Mobidiag
- Wondfo
What is the 10-year outlook for the global POCT Molecular Diagnostics market?
What factors are driving POCT Molecular Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POCT Molecular Diagnostics market opportunities vary by end market size?
How does POCT Molecular Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global POCT Molecular Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for POCT Molecular Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for POCT Molecular Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 POCT Molecular Diagnostics Segment by Type
2.2.1 Molecular Point-of-Care Diagnostics
2.2.2 Near-Patient Molecular
2.3 POCT Molecular Diagnostics Sales by Type
2.3.1 Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global POCT Molecular Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global POCT Molecular Diagnostics Sale Price by Type (2018-2023)
2.4 POCT Molecular Diagnostics Segment by Application
2.4.1 Microbiology Laboratory
2.4.2 Hospital
2.4.3 Clinic
2.5 POCT Molecular Diagnostics Sales by Application
2.5.1 Global POCT Molecular Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global POCT Molecular Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global POCT Molecular Diagnostics Sale Price by Application (2018-2023)
3 GLOBAL POCT MOLECULAR DIAGNOSTICS BY COMPANY
3.1 Global POCT Molecular Diagnostics Breakdown Data by Company
3.1.1 Global POCT Molecular Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global POCT Molecular Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global POCT Molecular Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global POCT Molecular Diagnostics Revenue by Company (2018-2023)
3.2.2 Global POCT Molecular Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global POCT Molecular Diagnostics Sale Price by Company
3.4 Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers POCT Molecular Diagnostics Product Location Distribution
3.4.2 Players POCT Molecular Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
4.1 World Historic POCT Molecular Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global POCT Molecular Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global POCT Molecular Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic POCT Molecular Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global POCT Molecular Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global POCT Molecular Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas POCT Molecular Diagnostics Sales Growth
4.4 APAC POCT Molecular Diagnostics Sales Growth
4.5 Europe POCT Molecular Diagnostics Sales Growth
4.6 Middle East & Africa POCT Molecular Diagnostics Sales Growth
5 AMERICAS
5.1 Americas POCT Molecular Diagnostics Sales by Country
5.1.1 Americas POCT Molecular Diagnostics Sales by Country (2018-2023)
5.1.2 Americas POCT Molecular Diagnostics Revenue by Country (2018-2023)
5.2 Americas POCT Molecular Diagnostics Sales by Type
5.3 Americas POCT Molecular Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POCT Molecular Diagnostics Sales by Region
6.1.1 APAC POCT Molecular Diagnostics Sales by Region (2018-2023)
6.1.2 APAC POCT Molecular Diagnostics Revenue by Region (2018-2023)
6.2 APAC POCT Molecular Diagnostics Sales by Type
6.3 APAC POCT Molecular Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe POCT Molecular Diagnostics by Country
7.1.1 Europe POCT Molecular Diagnostics Sales by Country (2018-2023)
7.1.2 Europe POCT Molecular Diagnostics Revenue by Country (2018-2023)
7.2 Europe POCT Molecular Diagnostics Sales by Type
7.3 Europe POCT Molecular Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa POCT Molecular Diagnostics by Country
8.1.1 Middle East & Africa POCT Molecular Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa POCT Molecular Diagnostics Sales by Type
8.3 Middle East & Africa POCT Molecular Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics
10.3 Manufacturing Process Analysis of POCT Molecular Diagnostics
10.4 Industry Chain Structure of POCT Molecular Diagnostics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 POCT Molecular Diagnostics Distributors
11.3 POCT Molecular Diagnostics Customer
12 WORLD FORECAST REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
12.1 Global POCT Molecular Diagnostics Market Size Forecast by Region
12.1.1 Global POCT Molecular Diagnostics Forecast by Region (2024-2029)
12.1.2 Global POCT Molecular Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global POCT Molecular Diagnostics Forecast by Type
12.7 Global POCT Molecular Diagnostics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ustar Biotechnologies (Hangzhou) Ltd.
13.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Company Information
13.1.2 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ustar Biotechnologies (Hangzhou) Ltd. Main Business Overview
13.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
13.2 Cepheid
13.2.1 Cepheid Company Information
13.2.2 Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
13.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cepheid Main Business Overview
13.2.5 Cepheid Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
13.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Information
13.4.2 Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
13.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Holding AG Main Business Overview
13.4.5 Roche Holding AG Latest Developments
13.5 BioFire Diagnostics
13.5.1 BioFire Diagnostics Company Information
13.5.2 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
13.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFire Diagnostics Main Business Overview
13.5.5 BioFire Diagnostics Latest Developments
13.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
13.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
13.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business Overview
13.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
13.7 CapitalBio Corporation
13.7.1 CapitalBio Corporation Company Information
13.7.2 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
13.7.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CapitalBio Corporation Main Business Overview
13.7.5 CapitalBio Corporation Latest Developments
13.8 Daan Gene
13.8.1 Daan Gene Company Information
13.8.2 Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
13.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Daan Gene Main Business Overview
13.8.5 Daan Gene Latest Developments
13.9 Sansure Biotech
13.9.1 Sansure Biotech Company Information
13.9.2 Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
13.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sansure Biotech Main Business Overview
13.9.5 Sansure Biotech Latest Developments
13.10 Coyote Bioscience Co., Ltd.
13.10.1 Coyote Bioscience Co., Ltd. Company Information
13.10.2 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Coyote Bioscience Co., Ltd. Main Business Overview
13.10.5 Coyote Bioscience Co., Ltd. Latest Developments
13.11 Genmark Diagnostics, Inc.
13.11.1 Genmark Diagnostics, Inc. Company Information
13.11.2 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
13.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Genmark Diagnostics, Inc. Main Business Overview
13.11.5 Genmark Diagnostics, Inc. Latest Developments
13.12 Mobidiag
13.12.1 Mobidiag Company Information
13.12.2 Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
13.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mobidiag Main Business Overview
13.12.5 Mobidiag Latest Developments
13.13 Wondfo
13.13.1 Wondfo Company Information
13.13.2 Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
13.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Wondfo Main Business Overview
13.13.5 Wondfo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global POCT Molecular Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for POCT Molecular Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for POCT Molecular Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 POCT Molecular Diagnostics Segment by Type
2.2.1 Molecular Point-of-Care Diagnostics
2.2.2 Near-Patient Molecular
2.3 POCT Molecular Diagnostics Sales by Type
2.3.1 Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global POCT Molecular Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global POCT Molecular Diagnostics Sale Price by Type (2018-2023)
2.4 POCT Molecular Diagnostics Segment by Application
2.4.1 Microbiology Laboratory
2.4.2 Hospital
2.4.3 Clinic
2.5 POCT Molecular Diagnostics Sales by Application
2.5.1 Global POCT Molecular Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global POCT Molecular Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global POCT Molecular Diagnostics Sale Price by Application (2018-2023)
3 GLOBAL POCT MOLECULAR DIAGNOSTICS BY COMPANY
3.1 Global POCT Molecular Diagnostics Breakdown Data by Company
3.1.1 Global POCT Molecular Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global POCT Molecular Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global POCT Molecular Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global POCT Molecular Diagnostics Revenue by Company (2018-2023)
3.2.2 Global POCT Molecular Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global POCT Molecular Diagnostics Sale Price by Company
3.4 Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers POCT Molecular Diagnostics Product Location Distribution
3.4.2 Players POCT Molecular Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
4.1 World Historic POCT Molecular Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global POCT Molecular Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global POCT Molecular Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic POCT Molecular Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global POCT Molecular Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global POCT Molecular Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas POCT Molecular Diagnostics Sales Growth
4.4 APAC POCT Molecular Diagnostics Sales Growth
4.5 Europe POCT Molecular Diagnostics Sales Growth
4.6 Middle East & Africa POCT Molecular Diagnostics Sales Growth
5 AMERICAS
5.1 Americas POCT Molecular Diagnostics Sales by Country
5.1.1 Americas POCT Molecular Diagnostics Sales by Country (2018-2023)
5.1.2 Americas POCT Molecular Diagnostics Revenue by Country (2018-2023)
5.2 Americas POCT Molecular Diagnostics Sales by Type
5.3 Americas POCT Molecular Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POCT Molecular Diagnostics Sales by Region
6.1.1 APAC POCT Molecular Diagnostics Sales by Region (2018-2023)
6.1.2 APAC POCT Molecular Diagnostics Revenue by Region (2018-2023)
6.2 APAC POCT Molecular Diagnostics Sales by Type
6.3 APAC POCT Molecular Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe POCT Molecular Diagnostics by Country
7.1.1 Europe POCT Molecular Diagnostics Sales by Country (2018-2023)
7.1.2 Europe POCT Molecular Diagnostics Revenue by Country (2018-2023)
7.2 Europe POCT Molecular Diagnostics Sales by Type
7.3 Europe POCT Molecular Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa POCT Molecular Diagnostics by Country
8.1.1 Middle East & Africa POCT Molecular Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa POCT Molecular Diagnostics Sales by Type
8.3 Middle East & Africa POCT Molecular Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics
10.3 Manufacturing Process Analysis of POCT Molecular Diagnostics
10.4 Industry Chain Structure of POCT Molecular Diagnostics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 POCT Molecular Diagnostics Distributors
11.3 POCT Molecular Diagnostics Customer
12 WORLD FORECAST REVIEW FOR POCT MOLECULAR DIAGNOSTICS BY GEOGRAPHIC REGION
12.1 Global POCT Molecular Diagnostics Market Size Forecast by Region
12.1.1 Global POCT Molecular Diagnostics Forecast by Region (2024-2029)
12.1.2 Global POCT Molecular Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global POCT Molecular Diagnostics Forecast by Type
12.7 Global POCT Molecular Diagnostics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ustar Biotechnologies (Hangzhou) Ltd.
13.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Company Information
13.1.2 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ustar Biotechnologies (Hangzhou) Ltd. Main Business Overview
13.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
13.2 Cepheid
13.2.1 Cepheid Company Information
13.2.2 Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
13.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cepheid Main Business Overview
13.2.5 Cepheid Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
13.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Information
13.4.2 Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
13.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Holding AG Main Business Overview
13.4.5 Roche Holding AG Latest Developments
13.5 BioFire Diagnostics
13.5.1 BioFire Diagnostics Company Information
13.5.2 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
13.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFire Diagnostics Main Business Overview
13.5.5 BioFire Diagnostics Latest Developments
13.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
13.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
13.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business Overview
13.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
13.7 CapitalBio Corporation
13.7.1 CapitalBio Corporation Company Information
13.7.2 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
13.7.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CapitalBio Corporation Main Business Overview
13.7.5 CapitalBio Corporation Latest Developments
13.8 Daan Gene
13.8.1 Daan Gene Company Information
13.8.2 Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
13.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Daan Gene Main Business Overview
13.8.5 Daan Gene Latest Developments
13.9 Sansure Biotech
13.9.1 Sansure Biotech Company Information
13.9.2 Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
13.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sansure Biotech Main Business Overview
13.9.5 Sansure Biotech Latest Developments
13.10 Coyote Bioscience Co., Ltd.
13.10.1 Coyote Bioscience Co., Ltd. Company Information
13.10.2 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
13.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Coyote Bioscience Co., Ltd. Main Business Overview
13.10.5 Coyote Bioscience Co., Ltd. Latest Developments
13.11 Genmark Diagnostics, Inc.
13.11.1 Genmark Diagnostics, Inc. Company Information
13.11.2 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
13.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Genmark Diagnostics, Inc. Main Business Overview
13.11.5 Genmark Diagnostics, Inc. Latest Developments
13.12 Mobidiag
13.12.1 Mobidiag Company Information
13.12.2 Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
13.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mobidiag Main Business Overview
13.12.5 Mobidiag Latest Developments
13.13 Wondfo
13.13.1 Wondfo Company Information
13.13.2 Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
13.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Wondfo Main Business Overview
13.13.5 Wondfo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. POCT Molecular Diagnostics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. POCT Molecular Diagnostics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Molecular Point-of-Care Diagnostics
Table 4. Major Players of Near-Patient Molecular
Table 5. Global POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 6. Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Table 7. Global POCT Molecular Diagnostics Revenue by Type (2018-2023) & ($ million)
Table 8. Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global POCT Molecular Diagnostics Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 11. Global POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Table 12. Global POCT Molecular Diagnostics Revenue by Application (2018-2023)
Table 13. Global POCT Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 14. Global POCT Molecular Diagnostics Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global POCT Molecular Diagnostics Sales by Company (2018-2023) & (K Units)
Table 16. Global POCT Molecular Diagnostics Sales Market Share by Company (2018-2023)
Table 17. Global POCT Molecular Diagnostics Revenue by Company (2018-2023) ($ Millions)
Table 18. Global POCT Molecular Diagnostics Revenue Market Share by Company (2018-2023)
Table 19. Global POCT Molecular Diagnostics Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution and Sales Area
Table 21. Players POCT Molecular Diagnostics Products Offered
Table 22. POCT Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global POCT Molecular Diagnostics Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global POCT Molecular Diagnostics Sales Market Share Geographic Region (2018-2023)
Table 27. Global POCT Molecular Diagnostics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global POCT Molecular Diagnostics Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global POCT Molecular Diagnostics Sales Market Share by Country/Region (2018-2023)
Table 31. Global POCT Molecular Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global POCT Molecular Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 34. Americas POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 35. Americas POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 37. Americas POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 38. Americas POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 39. APAC POCT Molecular Diagnostics Sales by Region (2018-2023) & (K Units)
Table 40. APAC POCT Molecular Diagnostics Sales Market Share by Region (2018-2023)
Table 41. APAC POCT Molecular Diagnostics Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC POCT Molecular Diagnostics Revenue Market Share by Region (2018-2023)
Table 43. APAC POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 44. APAC POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 45. Europe POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 46. Europe POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 47. Europe POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 49. Europe POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 50. Europe POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of POCT Molecular Diagnostics
Table 58. Key Market Challenges & Risks of POCT Molecular Diagnostics
Table 59. Key Industry Trends of POCT Molecular Diagnostics
Table 60. POCT Molecular Diagnostics Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. POCT Molecular Diagnostics Distributors List
Table 63. POCT Molecular Diagnostics Customer List
Table 64. Global POCT Molecular Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global POCT Molecular Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC POCT Molecular Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC POCT Molecular Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global POCT Molecular Diagnostics Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global POCT Molecular Diagnostics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global POCT Molecular Diagnostics Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global POCT Molecular Diagnostics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ustar Biotechnologies (Hangzhou) Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 79. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 80. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Ustar Biotechnologies (Hangzhou) Ltd. Main Business
Table 82. Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
Table 83. Cepheid Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 84. Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
Table 85. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Cepheid Main Business
Table 87. Cepheid Latest Developments
Table 88. Abbott Laboratories Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
Table 90. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Laboratories Main Business
Table 92. Abbott Laboratories Latest Developments
Table 93. Roche Holding AG Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
Table 95. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Roche Holding AG Main Business
Table 97. Roche Holding AG Latest Developments
Table 98. BioFire Diagnostics Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
Table 100. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. BioFire Diagnostics Main Business
Table 102. BioFire Diagnostics Latest Developments
Table 103. Beijing Bohui Innovat Biotech Grp Co Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 105. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business
Table 107. Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
Table 108. CapitalBio Corporation Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 109. CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
Table 110. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. CapitalBio Corporation Main Business
Table 112. CapitalBio Corporation Latest Developments
Table 113. Daan Gene Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 114. Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
Table 115. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Daan Gene Main Business
Table 117. Daan Gene Latest Developments
Table 118. Sansure Biotech Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 119. Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
Table 120. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sansure Biotech Main Business
Table 122. Sansure Biotech Latest Developments
Table 123. Coyote Bioscience Co., Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 124. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 125. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Coyote Bioscience Co., Ltd. Main Business
Table 127. Coyote Bioscience Co., Ltd. Latest Developments
Table 128. Genmark Diagnostics, Inc. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 129. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 130. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Genmark Diagnostics, Inc. Main Business
Table 132. Genmark Diagnostics, Inc. Latest Developments
Table 133. Mobidiag Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 134. Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
Table 135. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Mobidiag Main Business
Table 137. Mobidiag Latest Developments
Table 138. Wondfo Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 139. Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
Table 140. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Wondfo Main Business
Table 142. Wondfo Latest Developments
Table 1. POCT Molecular Diagnostics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. POCT Molecular Diagnostics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Molecular Point-of-Care Diagnostics
Table 4. Major Players of Near-Patient Molecular
Table 5. Global POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 6. Global POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Table 7. Global POCT Molecular Diagnostics Revenue by Type (2018-2023) & ($ million)
Table 8. Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global POCT Molecular Diagnostics Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 11. Global POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Table 12. Global POCT Molecular Diagnostics Revenue by Application (2018-2023)
Table 13. Global POCT Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 14. Global POCT Molecular Diagnostics Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global POCT Molecular Diagnostics Sales by Company (2018-2023) & (K Units)
Table 16. Global POCT Molecular Diagnostics Sales Market Share by Company (2018-2023)
Table 17. Global POCT Molecular Diagnostics Revenue by Company (2018-2023) ($ Millions)
Table 18. Global POCT Molecular Diagnostics Revenue Market Share by Company (2018-2023)
Table 19. Global POCT Molecular Diagnostics Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers POCT Molecular Diagnostics Producing Area Distribution and Sales Area
Table 21. Players POCT Molecular Diagnostics Products Offered
Table 22. POCT Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global POCT Molecular Diagnostics Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global POCT Molecular Diagnostics Sales Market Share Geographic Region (2018-2023)
Table 27. Global POCT Molecular Diagnostics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global POCT Molecular Diagnostics Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global POCT Molecular Diagnostics Sales Market Share by Country/Region (2018-2023)
Table 31. Global POCT Molecular Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global POCT Molecular Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 34. Americas POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 35. Americas POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 37. Americas POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 38. Americas POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 39. APAC POCT Molecular Diagnostics Sales by Region (2018-2023) & (K Units)
Table 40. APAC POCT Molecular Diagnostics Sales Market Share by Region (2018-2023)
Table 41. APAC POCT Molecular Diagnostics Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC POCT Molecular Diagnostics Revenue Market Share by Region (2018-2023)
Table 43. APAC POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 44. APAC POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 45. Europe POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 46. Europe POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 47. Europe POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 49. Europe POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 50. Europe POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa POCT Molecular Diagnostics Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa POCT Molecular Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa POCT Molecular Diagnostics Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa POCT Molecular Diagnostics Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of POCT Molecular Diagnostics
Table 58. Key Market Challenges & Risks of POCT Molecular Diagnostics
Table 59. Key Industry Trends of POCT Molecular Diagnostics
Table 60. POCT Molecular Diagnostics Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. POCT Molecular Diagnostics Distributors List
Table 63. POCT Molecular Diagnostics Customer List
Table 64. Global POCT Molecular Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global POCT Molecular Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC POCT Molecular Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC POCT Molecular Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa POCT Molecular Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa POCT Molecular Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global POCT Molecular Diagnostics Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global POCT Molecular Diagnostics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global POCT Molecular Diagnostics Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global POCT Molecular Diagnostics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ustar Biotechnologies (Hangzhou) Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 79. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 80. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Ustar Biotechnologies (Hangzhou) Ltd. Main Business
Table 82. Ustar Biotechnologies (Hangzhou) Ltd. Latest Developments
Table 83. Cepheid Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 84. Cepheid POCT Molecular Diagnostics Product Portfolios and Specifications
Table 85. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Cepheid Main Business
Table 87. Cepheid Latest Developments
Table 88. Abbott Laboratories Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories POCT Molecular Diagnostics Product Portfolios and Specifications
Table 90. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Laboratories Main Business
Table 92. Abbott Laboratories Latest Developments
Table 93. Roche Holding AG Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Holding AG POCT Molecular Diagnostics Product Portfolios and Specifications
Table 95. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Roche Holding AG Main Business
Table 97. Roche Holding AG Latest Developments
Table 98. BioFire Diagnostics Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFire Diagnostics POCT Molecular Diagnostics Product Portfolios and Specifications
Table 100. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. BioFire Diagnostics Main Business
Table 102. BioFire Diagnostics Latest Developments
Table 103. Beijing Bohui Innovat Biotech Grp Co Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 105. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Beijing Bohui Innovat Biotech Grp Co Ltd. Main Business
Table 107. Beijing Bohui Innovat Biotech Grp Co Ltd. Latest Developments
Table 108. CapitalBio Corporation Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 109. CapitalBio Corporation POCT Molecular Diagnostics Product Portfolios and Specifications
Table 110. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. CapitalBio Corporation Main Business
Table 112. CapitalBio Corporation Latest Developments
Table 113. Daan Gene Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 114. Daan Gene POCT Molecular Diagnostics Product Portfolios and Specifications
Table 115. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Daan Gene Main Business
Table 117. Daan Gene Latest Developments
Table 118. Sansure Biotech Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 119. Sansure Biotech POCT Molecular Diagnostics Product Portfolios and Specifications
Table 120. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sansure Biotech Main Business
Table 122. Sansure Biotech Latest Developments
Table 123. Coyote Bioscience Co., Ltd. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 124. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 125. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Coyote Bioscience Co., Ltd. Main Business
Table 127. Coyote Bioscience Co., Ltd. Latest Developments
Table 128. Genmark Diagnostics, Inc. Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 129. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolios and Specifications
Table 130. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Genmark Diagnostics, Inc. Main Business
Table 132. Genmark Diagnostics, Inc. Latest Developments
Table 133. Mobidiag Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 134. Mobidiag POCT Molecular Diagnostics Product Portfolios and Specifications
Table 135. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Mobidiag Main Business
Table 137. Mobidiag Latest Developments
Table 138. Wondfo Basic Information, POCT Molecular Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 139. Wondfo POCT Molecular Diagnostics Product Portfolios and Specifications
Table 140. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Wondfo Main Business
Table 142. Wondfo Latest Developments
LIST OF FIGURES
Figure 1. Picture of POCT Molecular Diagnostics
Figure 2. POCT Molecular Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global POCT Molecular Diagnostics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global POCT Molecular Diagnostics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. POCT Molecular Diagnostics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Molecular Point-of-Care Diagnostics
Figure 10. Product Picture of Near-Patient Molecular
Figure 11. Global POCT Molecular Diagnostics Sales Market Share by Type in 2022
Figure 12. Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Figure 13. POCT Molecular Diagnostics Consumed in Microbiology Laboratory
Figure 14. Global POCT Molecular Diagnostics Market: Microbiology Laboratory (2018-2023) & (K Units)
Figure 15. POCT Molecular Diagnostics Consumed in Hospital
Figure 16. Global POCT Molecular Diagnostics Market: Hospital (2018-2023) & (K Units)
Figure 17. POCT Molecular Diagnostics Consumed in Clinic
Figure 18. Global POCT Molecular Diagnostics Market: Clinic (2018-2023) & (K Units)
Figure 19. Global POCT Molecular Diagnostics Sales Market Share by Application (2022)
Figure 20. Global POCT Molecular Diagnostics Revenue Market Share by Application in 2022
Figure 21. POCT Molecular Diagnostics Sales Market by Company in 2022 (K Units)
Figure 22. Global POCT Molecular Diagnostics Sales Market Share by Company in 2022
Figure 23. POCT Molecular Diagnostics Revenue Market by Company in 2022 ($ Million)
Figure 24. Global POCT Molecular Diagnostics Revenue Market Share by Company in 2022
Figure 25. Global POCT Molecular Diagnostics Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region in 2022
Figure 27. Americas POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 28. Americas POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 29. APAC POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 30. APAC POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 31. Europe POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 32. Europe POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 35. Americas POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 36. Americas POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 37. Americas POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 38. Americas POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 39. United States POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC POCT Molecular Diagnostics Sales Market Share by Region in 2022
Figure 44. APAC POCT Molecular Diagnostics Revenue Market Share by Regions in 2022
Figure 45. APAC POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 46. APAC POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 47. China POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 51. India POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 55. Europe POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 56. Europe POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 57. Europe POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 58. Germany POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 59. France POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 64. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 67. Egypt POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics in 2022
Figure 73. Manufacturing Process Analysis of POCT Molecular Diagnostics
Figure 74. Industry Chain Structure of POCT Molecular Diagnostics
Figure 75. Channels of Distribution
Figure 76. Global POCT Molecular Diagnostics Sales Market Forecast by Region (2024-2029)
Figure 77. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global POCT Molecular Diagnostics Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global POCT Molecular Diagnostics Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of POCT Molecular Diagnostics
Figure 2. POCT Molecular Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global POCT Molecular Diagnostics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global POCT Molecular Diagnostics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. POCT Molecular Diagnostics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Molecular Point-of-Care Diagnostics
Figure 10. Product Picture of Near-Patient Molecular
Figure 11. Global POCT Molecular Diagnostics Sales Market Share by Type in 2022
Figure 12. Global POCT Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Figure 13. POCT Molecular Diagnostics Consumed in Microbiology Laboratory
Figure 14. Global POCT Molecular Diagnostics Market: Microbiology Laboratory (2018-2023) & (K Units)
Figure 15. POCT Molecular Diagnostics Consumed in Hospital
Figure 16. Global POCT Molecular Diagnostics Market: Hospital (2018-2023) & (K Units)
Figure 17. POCT Molecular Diagnostics Consumed in Clinic
Figure 18. Global POCT Molecular Diagnostics Market: Clinic (2018-2023) & (K Units)
Figure 19. Global POCT Molecular Diagnostics Sales Market Share by Application (2022)
Figure 20. Global POCT Molecular Diagnostics Revenue Market Share by Application in 2022
Figure 21. POCT Molecular Diagnostics Sales Market by Company in 2022 (K Units)
Figure 22. Global POCT Molecular Diagnostics Sales Market Share by Company in 2022
Figure 23. POCT Molecular Diagnostics Revenue Market by Company in 2022 ($ Million)
Figure 24. Global POCT Molecular Diagnostics Revenue Market Share by Company in 2022
Figure 25. Global POCT Molecular Diagnostics Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global POCT Molecular Diagnostics Revenue Market Share by Geographic Region in 2022
Figure 27. Americas POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 28. Americas POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 29. APAC POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 30. APAC POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 31. Europe POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 32. Europe POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa POCT Molecular Diagnostics Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa POCT Molecular Diagnostics Revenue 2018-2023 ($ Millions)
Figure 35. Americas POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 36. Americas POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 37. Americas POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 38. Americas POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 39. United States POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC POCT Molecular Diagnostics Sales Market Share by Region in 2022
Figure 44. APAC POCT Molecular Diagnostics Revenue Market Share by Regions in 2022
Figure 45. APAC POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 46. APAC POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 47. China POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 51. India POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 55. Europe POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 56. Europe POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 57. Europe POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 58. Germany POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 59. France POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Country in 2022
Figure 64. Middle East & Africa POCT Molecular Diagnostics Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa POCT Molecular Diagnostics Sales Market Share by Application (2018-2023)
Figure 67. Egypt POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country POCT Molecular Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of POCT Molecular Diagnostics in 2022
Figure 73. Manufacturing Process Analysis of POCT Molecular Diagnostics
Figure 74. Industry Chain Structure of POCT Molecular Diagnostics
Figure 75. Channels of Distribution
Figure 76. Global POCT Molecular Diagnostics Sales Market Forecast by Region (2024-2029)
Figure 77. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global POCT Molecular Diagnostics Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global POCT Molecular Diagnostics Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global POCT Molecular Diagnostics Revenue Market Share Forecast by Application (2024-2029)
